Your browser doesn't support javascript.
loading
Integrated multi-omics reveal polycomb repressive complex 2 restricts human trophoblast induction.
Zijlmans, Dick W; Talon, Irene; Verhelst, Sigrid; Bendall, Adam; Van Nerum, Karlien; Javali, Alok; Malcolm, Andrew A; van Knippenberg, Sam S F A; Biggins, Laura; To, San Kit; Janiszewski, Adrian; Admiraal, Danielle; Knops, Ruth; Corthout, Nikky; Balaton, Bradley P; Georgolopoulos, Grigorios; Panda, Amitesh; Bhanu, Natarajan V; Collier, Amanda J; Fabian, Charlene; Allsop, Ryan N; Chappell, Joel; Pham, Thi Xuan Ai; Oberhuemer, Michael; Ertekin, Cankat; Vanheer, Lotte; Athanasouli, Paraskevi; Lluis, Frederic; Deforce, Dieter; Jansen, Joop H; Garcia, Benjamin A; Vermeulen, Michiel; Rivron, Nicolas; Dhaenens, Maarten; Marks, Hendrik; Rugg-Gunn, Peter J; Pasque, Vincent.
Afiliação
  • Zijlmans DW; Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Oncode Institute, Radboud University Nijmegen, Nijmegen, The Netherlands.
  • Talon I; Department of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.
  • Verhelst S; ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium.
  • Bendall A; Epigenetics Programme, Babraham Institute, Cambridge, UK.
  • Van Nerum K; Department of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.
  • Javali A; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.
  • Malcolm AA; Epigenetics Programme, Babraham Institute, Cambridge, UK.
  • van Knippenberg SSFA; The Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
  • Biggins L; Department of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.
  • To SK; Bioinformatics Group, Babraham Institute, Cambridge, UK.
  • Janiszewski A; Department of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.
  • Admiraal D; Department of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.
  • Knops R; Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Nijmegen, Nijmegen, The Netherlands.
  • Corthout N; Laboratory of Hematology, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre (RadboudUMC), Nijmegen, the Netherlands.
  • Balaton BP; VIB Center for Brain and Disease Research, KU Leuven, VIB Bioimaging Core, Leuven, Belgium.
  • Georgolopoulos G; Department of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.
  • Panda A; Department of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.
  • Bhanu NV; Department of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.
  • Collier AJ; Epigenetics Institute, Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Fabian C; Epigenetics Programme, Babraham Institute, Cambridge, UK.
  • Allsop RN; Epigenetics Programme, Babraham Institute, Cambridge, UK.
  • Chappell J; Department of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.
  • Pham TXA; Department of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.
  • Oberhuemer M; Department of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.
  • Ertekin C; Department of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.
  • Vanheer L; Department of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.
  • Athanasouli P; Department of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.
  • Lluis F; Department of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.
  • Deforce D; Department of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.
  • Jansen JH; ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium.
  • Garcia BA; Laboratory of Hematology, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre (RadboudUMC), Nijmegen, the Netherlands.
  • Vermeulen M; Epigenetics Institute, Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Rivron N; Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Oncode Institute, Radboud University Nijmegen, Nijmegen, The Netherlands.
  • Dhaenens M; Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Nijmegen, Nijmegen, The Netherlands.
  • Marks H; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.
  • Rugg-Gunn PJ; ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium. Maarten.Dhaenens@UGent.be.
  • Pasque V; Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Nijmegen, Nijmegen, The Netherlands. Hendrik.Marks@ru.nl.
Nat Cell Biol ; 24(6): 858-871, 2022 06.
Article em En | MEDLINE | ID: mdl-35697783
Human naive pluripotent stem cells have unrestricted lineage potential. Underpinning this property, naive cells are thought to lack chromatin-based lineage barriers. However, this assumption has not been tested. Here we define the chromatin-associated proteome, histone post-translational modifications and transcriptome of human naive and primed pluripotent stem cells. Our integrated analysis reveals differences in the relative abundance and activities of distinct chromatin modules. We identify a strong enrichment of polycomb repressive complex 2 (PRC2)-associated H3K27me3 in the chromatin of naive pluripotent stem cells and H3K27me3 enrichment at promoters of lineage-determining genes, including trophoblast regulators. PRC2 activity acts as a chromatin barrier restricting the differentiation of naive cells towards the trophoblast lineage, whereas inhibition of PRC2 promotes trophoblast-fate induction and cavity formation in human blastoids. Together, our results establish that human naive pluripotent stem cells are not epigenetically unrestricted, but instead possess chromatin mechanisms that oppose the induction of alternative cell fates.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Pluripotentes / Complexo Repressor Polycomb 2 Limite: Humans Idioma: En Revista: Nat Cell Biol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Pluripotentes / Complexo Repressor Polycomb 2 Limite: Humans Idioma: En Revista: Nat Cell Biol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda